Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Atara Biotherapeutics (ATRA) Receivables - Net (2021 - 2025)

Atara Biotherapeutics filings provide 5 years of Receivables - Net readings, the most recent being $1.3 million for Q4 2025.

  • On a quarterly basis, Receivables - Net fell 15.45% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 million, a 15.45% decrease, with the full-year FY2025 number at $1.3 million, down 15.45% from a year prior.
  • Receivables - Net hit $1.3 million in Q4 2025 for Atara Biotherapeutics, down from $1.9 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $40.2 million in Q4 2022 to a low of $163000.0 in Q3 2023.
  • Median Receivables - Net over the past 5 years was $1.3 million (2024), compared with a mean of $8.2 million.
  • The widest YoY moves for Receivables - Net: up 8926.2% in 2024, down 95.65% in 2024.
  • Atara Biotherapeutics' Receivables - Net stood at $986000.0 in 2021, then soared by 3979.21% to $40.2 million in 2022, then fell by 15.2% to $34.1 million in 2023, then plummeted by 95.65% to $1.5 million in 2024, then decreased by 15.45% to $1.3 million in 2025.
  • The last three reported values for Receivables - Net were $1.3 million (Q4 2025), $1.9 million (Q3 2025), and $8.9 million (Q1 2025) per Business Quant data.